Key result
Depressive symptoms significantly attenuated the improvement in peak oxygen uptake (mean difference -1.1 mL/kg/min) during a 3-month exercise-based cardiac rehabilitation program after LVAD implantation.
Why the study?
Although depressive symptoms are linked to increased readmission after LVAD implantation, it was unclear whether they affect the efficacy of exercise-based cardiac rehabilitation.
Do depressive symptoms reduce the improvement in exercise capacity from exercise-based cardiac rehabilitation in patients after left ventricular assist device implantation?
Observational (n=48)
No
Do depressive symptoms reduce the improvement in exercise capacity from exercise-based cardiac rehabilitation in patients after left ventricular assist device implantation?
Mean Difference: -1.1 (95% CI -2.17–-0.045)
Absolute Event Rate: 1.6% vs 2.7%
p-value: p=0.041
Depressive symptoms significantly attenuate the improvement in exercise capacity (peak VO2) gained from cardiac rehabilitation after LVAD implantation, highlighting the potential need for concurrent psychological interventions.
Depressive symptoms were associated with blunted peak VO2 gains post-LVAD rehab; hypothesis-generating for integrated psychological support in future trials.
Background Although depressive symptoms are associated with an increased risk of readmission after left ventricular assist device (LVAD) implantation, it is unclear whether they affect the efficacy of exercise‐based cardiac rehabilitation (EBCR). This study aimed to investigate the effect of depressive symptoms on EBCR efficacy. Methods We analyzed 48 patients who participated in EBCR after LVAD implantation (mean age 45 ± 12 years; 60% male). Patients were classified into two groups using the Zung Self‐Rating Depression Scale (SDS): depressive group (SDS ≥40, n = 27) and non‐depressive group (SDS <40, n = 21). We examined changes in peak oxygen uptake (VO2), knee extensor muscular strength (KEMS), and quality of life (QOL) during EBCR using analysis of covariance. Results Although baseline characteristics were similar between the two groups, the non‐depressive group was less likely to receive diuretics (22% vs. 52%, p = 0.030). Peak VO2, KEMS, and QOL significantly increased over time in both groups (all p < 0.05). The depressive group had a significantly lower change in peak VO2 than the non‐depressive group (2.7 vs. 1.6 ml/kg/min; mean difference: −1.1 ml/kg/min, 95% confidence interval [CI]: −0.045 to −2.17; p = 0.041, d = 0.59). There was no between‐group difference regarding the change in KEMS or QOL. Adjusting for the baseline value, a significant difference between groups was observed only in peak VO2 (p = 0.045). Conclusions Although EBCR significantly improved exercise capacity after LVAD implantation, depressive symptoms interfered with this improvement. Further studies are needed to determine whether psychological interventions for depression, in addition to EBCR, would improve the response to EBCR after LVAD implantation.
No takes yet. Share an insight, caveat, or question.
Kitagaki et al. (2021) conducted an observational in Heart failure after left ventricular assist device (LVAD) implantation (n=48). Depressive symptoms (SDS ≥40) vs. Non-depressive symptoms (SDS <40) was evaluated on Change in peak oxygen uptake (VO2) (MD -1.1 mL/kg/min, 95% CI -0.045 - -2.17, p=0.041). Depressive symptoms significantly attenuated the improvement in peak oxygen uptake (mean difference -1.1 mL/kg/min) during a 3-month exercise-based cardiac rehabilitation program after LVAD implantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: